# Veltex Corporation (VLXC)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/VLXC/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 1.43M | $ -1.21M | $ -152.1K | $ 3.20M | $ -2.87M |
| 2024 | $ 1.62M | $ -878.1K | $ -414.6K | $ 2.49M | $ -1.61M |
| 2023 | $ 1.27M | $ -646.7K | $ -236.7K | $ 2.18M | $ -1.07M |
| 2022 | $ 34.4K | $ -4.34M | $ -639.2K | $ 1.31M | $ -581.3K |
| 2021 | $ 4.6K | $ -3.82M | $ -598.3K | $ 784.9K | $ 208.1K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -1.11 |
| Liabilities / Eq | -1.63 |
| Current Ratio | 0.20 |

## Other views

- [Metrics](https://sponda.capital/en/VLXC.md)
- [Charts](https://sponda.capital/en/VLXC/charts.md)
- [Compare](https://sponda.capital/en/VLXC/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.